Young-Seok Byun - Publications

Affiliations: 
1985-1990 Chemistry University of Nevada, Reno, Reno, NV, United States 

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Kwon H, Kim Y, Park K, Choi SA, Son SH, Byun Y. Structure-based design, synthesis, and biological evaluation of Leu-Arg dipeptide analogs as novel hepsin inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 26711145 DOI: 10.1016/j.bmcl.2015.12.023  0.32
2015 Youn S, Kim KI, Ptacek J, Ok K, Novakova Z, Kim Y, Koo J, Barinka C, Byun Y. Carborane-containing urea-based inhibitors of glutamate carboxypeptidase II: Synthesis and structural characterization. Bioorganic & Medicinal Chemistry Letters. PMID 26459214 DOI: 10.1016/j.bmcl.2015.09.062  0.32
2015 Barth RF, Yang W, Nakkula RJ, Byun Y, Tjarks W, Chu Wu L, Binns PJ, Riley KJ. Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. PMID 26282567 DOI: 10.1016/j.apradiso.2015.06.031  0.32
2015 Agarwal HK, Khalil A, Ishita K, Yang W, Nakkula RJ, Wu LC, Ali T, Tiwari R, Byun Y, Barth RF, Tjarks W. Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer. European Journal of Medicinal Chemistry. 100: 197-209. PMID 26087030 DOI: 10.1016/j.ejmech.2015.05.042  0.32
2015 Park S, Kim HS, Ok K, Kim Y, Park HD, Byun Y. Design, synthesis and biological evaluation of 4-(alkyloxy)-6-methyl-2H-pyran-2-one derivatives as quorum sensing inhibitors. Bioorganic & Medicinal Chemistry Letters. 25: 2913-7. PMID 26048802 DOI: 10.1016/j.bmcl.2015.05.054  0.32
2015 Kang N, Bahk YY, Lee N, Jae Y, Cho YH, Ku CR, Byun Y, Lee EJ, Kim MS, Koo J. Olfactory receptor Olfr544 responding to azelaic acid regulates glucagon secretion in α-cells of mouse pancreatic islets. Biochemical and Biophysical Research Communications. 460: 616-21. PMID 25804639 DOI: 10.1016/j.bbrc.2015.03.078  0.32
2015 Kim HS, Lee SH, Byun Y, Park HD. 6-Gingerol reduces Pseudomonas aeruginosa biofilm formation and virulence via quorum sensing inhibition. Scientific Reports. 5: 8656. PMID 25728862 DOI: 10.1038/srep08656  0.32
2015 Subedi M, Chen J, Kang E, Kim KI, Byun Y. Facile Synthesis of 2-(4-Hydroxybiphenyl-3-yl)-1H-Indoles from Anilines and 5′-Bromo-2′-Hydroxyacetophenone Synthetic Communications. 45: 1704-1709. DOI: 10.1080/00397911.2015.1043390  0.32
2015 Chen J, Kim Y, Park Y, Byun Y, Kang J. Simultaneous determination of six compounds in Wen-Pi-Tang-Hab-Wu-Ling-San using an HPLC-DAD method and application in a pharmacokinetic study Journal of the Chinese Chemical Society. 62: 439-442. DOI: 10.1002/jccs.201400488  0.32
2014 Minn I, Wang H, Mease RC, Byun Y, Yang X, Wang J, Leach SD, Pomper MG. A red-shifted fluorescent substrate for aldehyde dehydrogenase. Nature Communications. 5: 3662. PMID 24759454 DOI: 10.1038/ncomms4662  0.32
2014 Pavlicek J, Ptacek J, Cerny J, Byun Y, Skultetyova L, Pomper MG, Lubkowski J, Barinka C. Structural characterization of P1'-diversified urea-based inhibitors of glutamate carboxypeptidase II. Bioorganic & Medicinal Chemistry Letters. 24: 2340-5. PMID 24731280 DOI: 10.1016/j.bmcl.2014.03.066  0.32
2014 Kim KH, Yeon SM, Kim HG, Choi HS, Kang H, Park HD, Park TW, Pack SP, Lee EH, Byun Y, Choi SE, Lee KS, Ha UH, Jung YW. Diverse influences of androgen-disrupting chemicals on immune responses mounted by macrophages. Inflammation. 37: 649-56. PMID 24287822 DOI: 10.1007/s10753-013-9781-1  0.32
2014 Kim KH, Yeon SM, Kim HG, Lee H, Kim SK, Han SH, Min KJ, Byun Y, Lee EH, Lee KS, Yuk SH, Ha UH, Jung YW. Single-walled carbon nanotubes induce cell death and transcription of TNF-α in macrophages without affecting nitric oxide production. Inflammation. 37: 44-54. PMID 23955578 DOI: 10.1007/s10753-013-9710-3  0.32
2014 Choi S, Kim Y, Park BB, Park S, Park J, Ok K, Koo J, Jung YW, Jeon YH, Lee EH, Lee KS, Byun Y. X-ray diffraction and VT-NMR studies of (E)-3-(piperidinyl)-1-(2′-hydroxyphenyl)-prop-2-en-1-one Journal of Molecular Structure. 1076: 600-605. DOI: 10.1016/j.molstruc.2014.08.016  0.32
2013 Byun Y, Pullambhatla M, Wang H, Mease RC, Pomper MG. Synthesis and Biological Evaluation of Substrate-Based Imaging Agents for the Prostate-Specific Membrane Antigen. Macromolecular Research. 21: 565-573. PMID 25328507 DOI: 10.1007/s13233-013-1050-5  0.32
2013 Park MH, Park JY, Lee HJ, Kim DH, Chung KW, Park D, Jeong HO, Kim HR, Park CH, Kim SR, Chun P, Byun Y, Moon HR, Chung HY. The novel PPAR α/γ dual agonist MHY 966 modulates UVB-induced skin inflammation by inhibiting NF-κB activity. Plos One. 8: e76820. PMID 24130794 DOI: 10.1371/journal.pone.0076820  0.32
2013 Lee J, Boerrigter SX, Jung YW, Byun Y, Yuk SH, Byrn SR, Lee EH. Organic vapor sorption method of isostructural solvates and polymorph of tenofovir disoproxil fumarate. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 50: 253-62. PMID 23872626 DOI: 10.1016/j.ejps.2013.07.004  0.32
2013 Koo J, Byun Y. Current status of PET-imaging probes of β-amyloid plaques. Archives of Pharmacal Research. 36: 1178-84. PMID 23812777 DOI: 10.1007/s12272-013-0193-4  0.32
2013 Kim SH, Choi YJ, Moon KM, Lee HJ, Woo Y, Chung KW, Jung Y, Kim S, Chun P, Byun Y, Ha YM, Moon HR, Chung HY. The inhibitory effect of a synthetic compound, (Z)-5-(2,4- dihydroxybenzylidene) thiazolidine-2,4-dione (MHY498), on nitric oxide-induced melanogenesis Bioorganic and Medicinal Chemistry Letters. 23: 4332-4335. PMID 23806552 DOI: 10.1016/j.bmcl.2013.05.094  0.32
2013 Ray Banerjee S, Pullambhatla M, Foss CA, Falk A, Byun Y, Nimmagadda S, Mease RC, Pomper MG. Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA). Journal of Medicinal Chemistry. 56: 6108-21. PMID 23799782 DOI: 10.1021/jm400823w  0.32
2013 Chung KW, Jeong HO, Jang EJ, Choi YJ, Kim DH, Kim SR, Lee KJ, Lee HJ, Chun P, Byun Y, Moon HR, Chung HY. Characterization of a small molecule inhibitor of melanogenesis that inhibits tyrosinase activity and scavenges nitric oxide (NO). Biochimica Et Biophysica Acta. 1830: 4752-61. PMID 23769841 DOI: 10.1016/j.bbagen.2013.06.002  0.32
2013 Park JW, Ha YM, Moon KM, Moon KM, Kim SR, Jeong HO, Park YJ, Lee HJ, Park JY, Song YM, Chun P, Byun Y, Moon HR, Chung HY. De novo tyrosinase inhibitor: 4-(6,7-dihydro-5H-indeno[5,6-d]thiazol-2-yl)benzene-1,3-diol (MHY1556). Bioorganic & Medicinal Chemistry Letters. 23: 4172-6. PMID 23743286 DOI: 10.1016/j.bmcl.2013.05.029  0.32
2013 Byun Y, Park J, Hong SH, Han MH, Park S, Jung HI, Noh M. The opposite effect of isotype-selective monoamine oxidase inhibitors on adipogenesis in human bone marrow mesenchymal stem cells. Bioorganic & Medicinal Chemistry Letters. 23: 3273-6. PMID 23611731 DOI: 10.1016/j.bmcl.2013.03.117  0.32
2013 Kim HJ, Alam Z, Hwang JW, Hwang YH, Kim MJ, Yoon S, Byun Y, Lee DY. Optimal formation of genetically modified and functional pancreatic islet spheroids by using hanging-drop strategy Transplantation Proceedings. 45: 605-610. PMID 23498797 DOI: 10.1016/j.transproceed.2012.11.014  0.32
2013 Lee K, Kim M, Lee B, Goo J, Kim J, Naik R, Seo JH, Kim MO, Byun Y, Song GY, Lee HS, Choi Y. Discovery of indolyl acrylamide derivatives as human diacylglycerol acyltransferase-2 selective inhibitors. Organic & Biomolecular Chemistry. 11: 849-58. PMID 23242135 DOI: 10.1039/c2ob27114a  0.32
2013 Chen J, Yan X, Kim KT, Kim SH, Lee ES, Lee YK, Son CG, Lee EH, Park YK, Cho CW, Kim YH, Byun Y, Kang JS. Comparative pharmacokinetics of berberine after oral administration of pure berberine, coptidis rhizoma extract, and decoctions of two different complex herbal formulas to rats Bulletin of the Korean Chemical Society. 34: 1559-1562. DOI: 10.5012/bkcs.2013.34.5.1559  0.32
2013 Ok K, Jung YW, Jee JG, Byun Y. Facile docking and scoring studies of carborane ligands with estrogen receptor Bulletin of the Korean Chemical Society. 34: 1051-1054. DOI: 10.5012/bkcs.2013.34.4.1051  0.32
2013 Lee J, Park S, Yoon SJ, Jung YW, Byun Y, Yuk SH, Jeon MK, Kang SK, Lee EH. Multicomponent system of NPS-1034, an orally administered lung cancer drug candidate, with sulfonic acids and solid state characterization Crystal Growth and Design. 13: 3958-3968. DOI: 10.1021/cg400651f  0.32
2013 Choi S, Byun Y. Synthesis of sterically-hindered 1,7-dicarba-closo-dodecarborane thiourea analogs Journal of Organometallic Chemistry. 733: 49-52. DOI: 10.1016/j.jorganchem.2013.03.003  0.32
2013 Kim HG, Jo SH, Yeon SM, Kim KH, Chung JW, Park TW, Byun Y, Lee EH, Park YI, Jung YW. Pluronic nanoparticles do not modulate immune responses mounted by macrophages Macromolecular Research. 21: 1355-1359. DOI: 10.1007/s13233-013-1174-7  0.32
2012 Chen Y, Pullambhatla M, Banerjee. SR, Byun Y, Stathis M, Rojas C, Slusher BS, Mease RC, Pomper MG. SYnthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen Bioconjugate Chemistry. 23: 2377-2385. PMID 23157641 DOI: 10.1021/bc3003919  0.32
2012 Song YM, Ha YM, Kim JA, Chung KW, Uehara Y, Lee KJ, Chun P, Byun Y, Chung HY, Moon HR. Synthesis of novel azo-resveratrol, azo-oxyresveratrol and their derivatives as potent tyrosinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22: 7451-5. PMID 23142612 DOI: 10.1016/j.bmcl.2012.10.050  0.32
2012 Alquicer G, Sedlák D, Byun Y, Pavlíček J, Stathis M, Rojas C, Slusher B, Pomper MG, Bartůněk P, Bařinka C. Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase II Journal of Biomolecular Screening. 17: 1030-1040. PMID 22751730 DOI: 10.1177/1087057112451924  0.32
2012 Tiwari R, Toppino A, Agarwal HK, Huo T, Byun Y, Gallucci J, Hasabelnaby S, Khalil A, Goudah A, Baiocchi RA, Darby MV, Barth RF, Tjarks W. Synthesis, biological evaluation, and radioiodination of halogenated closo-carboranylthymidine analogues. Inorganic Chemistry. 51: 629-39. PMID 22175713 DOI: 10.1021/ic202150b  0.32
2011 Chen Y, Pullambhatla M, Foss CA, Byun Y, Nimmagadda S, Senthamizhchelvan S, Sgouros G, Mease RC, Pomper MG. 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7645-53. PMID 22042970 DOI: 10.1158/1078-0432.CCR-11-1357  0.32
2011 Plechanovová A, Byun Y, Alquicer G, Skultétyová L, Mlčochová P, Němcová A, Kim HJ, Navrátil M, Mease R, Lubkowski J, Pomper M, Konvalinka J, Rulíšek L, Bařinka C. Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity. Journal of Medicinal Chemistry. 54: 7535-46. PMID 21923190 DOI: 10.1021/jm200807m  0.32
2011 Banerjee SR, Pullambhatla M, Byun Y, Nimmagadda S, Foss CA, Green G, Fox JJ, Lupold SE, Mease RC, Pomper MG. Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen. Angewandte Chemie (International Ed. in English). 50: 9167-70. PMID 21861274 DOI: 10.1002/anie.201102872  0.32
2010 Banerjee SR, Pullambhatla M, Byun Y, Nimmagadda S, Green G, Fox JJ, Horti A, Mease RC, Pomper MG. 68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer. Journal of Medicinal Chemistry. 53: 5333-41. PMID 20568777 DOI: 10.1021/jm100623e  0.32
2010 Wang H, Byun Y, Barinka C, Pullambhatla M, Bhang HE, Fox JJ, Lubkowski J, Mease RC, Pomper MG. Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies. Bioorganic & Medicinal Chemistry Letters. 20: 392-7. PMID 19897367 DOI: 10.1016/j.bmcl.2009.10.061  0.32
2009 Chen Y, Dhara S, Banerjee SR, Byun Y, Pullambhatla M, Mease RC, Pomper MG. A low molecular weight PSMA-based fluorescent imaging agent for cancer Biochemical and Biophysical Research Communications. 390: 624-629. PMID 19818734 DOI: 10.1016/j.bbrc.2009.10.017  0.32
2009 Zhang Y, Byun Y, Ren YR, Liu JO, Laterra J, Pomper MG. Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay Cancer Research. 69: 5867-5875. PMID 19567678 DOI: 10.1158/0008-5472.CAN-08-4866  0.32
2009 Byun Y, Mease RC, Lupold SE, Pomper MG. Recent Development of Diagnostic and Therapeutic Agents Targeting Glutamate Carboxypeptidase II (GCPII) Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications. 881-910. DOI: 10.1002/9780470508169.ch36  0.32
2008 Chen Y, Foss CA, Byun Y, Nimmagadda S, Pullambhatla M, Fox JJ, Castanares M, Lupold SE, Babich JW, Mease RC, Pomper MG. Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer. Journal of Medicinal Chemistry. 51: 7933-43. PMID 19053825 DOI: 10.1021/jm801055h  0.32
2008 Barinka C, Byun Y, Dusich CL, Banerjee SR, Chen Y, Castanares M, Kozikowski AP, Mease RC, Pomper MG, Lubkowski J. Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: Structural characterization Journal of Medicinal Chemistry. 51: 7737-7743. PMID 19053759 DOI: 10.1021/jm800765e  0.32
2008 Barth RF, Yang W, Wu G, Swindall M, Byun Y, Narayanasamy S, Tjarks W, Tordoff K, Moeschberger ML, Eriksson S, Binns PJ, Riley KJ. Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors. Proceedings of the National Academy of Sciences of the United States of America. 105: 17493-7. PMID 18981415 DOI: 10.1073/pnas.0809569105  0.32
2008 Banerjee SR, Foss CA, Castanares M, Mease RC, Byun Y, Fox JJ, Hilton J, Lupold SE, Kozikowski AP, Pomper MG. Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA) Journal of Medicinal Chemistry. 51: 4504-4517. PMID 18637669 DOI: 10.1021/jm800111u  0.32
2008 Byun Y, Vogel SR, Phipps AJ, Carnrot C, Eriksson S, Tiwari R, Tjarks W. Synthesis and biological evaluation of inhibitors of thymidine monophosphate kinase from Bacillus anthracis Nucleosides, Nucleotides and Nucleic Acids. 27: 244-260. PMID 18260009 DOI: 10.1080/15257770701845238  0.32
2007 Tjarks W, Tiwari R, Byun Y, Narayanasamy S, Barth RF. Carboranyl thymidine analogues for neutron capture therapy Chemical Communications. 4978-4991. PMID 18049729 DOI: 10.1039/b707257k  0.32
2006 Carnrot C, Vogel SR, Byun Y, Wang L, Tjarks W, Eriksson S, Phipps AJ. Evaluation of Bacillus anthracis thymidine kinase as a potential target for the development of antibacterial nucleoside analogs Biological Chemistry. 387: 1575-1581. PMID 17132103 DOI: 10.1515/BC.2006.196  0.32
2006 Byun Y, Thirumamagal BTS, Yang W, Eriksson S, Barth RF, Tjarks W. Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors Journal of Medicinal Chemistry. 49: 5513-5523. PMID 16942024 DOI: 10.1021/jm060413w  0.32
2006 Thirumamagal B, Johnsamuel J, Cosquer G, Byun Y, Yan J, Narayanasamy S, Tjarks W, Barth R, Al-Madhoun A, Eriksson S. Boronated thymidine analogues for boron neutron capture therapy Nucleosides, Nucleotides and Nucleic Acids. 25: 861-866. PMID 16901817 DOI: 10.1080/15257770600793844  0.32
2006 Narayanasamy S, Thirumamagal BTS, Johnsamuel J, Byun Y, Al-Madhoun AS, Usova E, Cosquer GY, Yan J, Bandyopadhyaya AK, Tiwari R, Eriksson S, Tjarks W. Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancer Bioorganic and Medicinal Chemistry. 14: 6886-6899. PMID 16831554 DOI: 10.1016/j.bmc.2006.06.039  0.32
2006 Byun Y, Narayanasamy S, Johnsamuel J, Bandyopadhyaya AK, Tiwari R, Al-Madhoun AS, Barth RF, Eriksson S, Tjarks W. 3-carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapy Anti-Cancer Agents in Medicinal Chemistry. 6: 127-144. PMID 16529536 DOI: 10.2174/187152006776119171  0.32
2006 Byun Y, Tjarks W. Investigation of zwitterionic 7-ammonium-7,9-nido-m-carborane Tetrahedron Letters. 47: 5649-5652. DOI: 10.1016/j.tetlet.2006.06.020  0.32
2005 Byun Y, Yan J, Al-Madhoun AS, Johnsamuel J, Yang W, Barth RF, Eriksson S, Tjarks W. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy Journal of Medicinal Chemistry. 48: 1188-1198. PMID 15715485 DOI: 10.1021/jm0491896  0.32
2004 Barth RF, Yang W, Al-Madhoun AS, Johnsamuel J, Byun Y, Chandra S, Smith DR, Tjarks W, Eriksson S. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors Cancer Research. 64: 6287-6295. PMID 15342417 DOI: 10.1158/0008-5472.CAN-04-0437  0.32
2004 Johnsamuel J, Lakhi N, Al-Madhoun AS, Byun Y, Yan J, Eriksson S, Tjarks W. Synthesis of ethyleneoxide modified 3-carboranyl thymidine analogues and evaluation of their biochemical, physicochemical, and structural properties Bioorganic and Medicinal Chemistry. 12: 4769-4781. PMID 15336255 DOI: 10.1016/j.bmc.2004.07.032  0.32
2004 Byun Y, Yan J, Al-Madhoun AS, Johnsamuel J, Yang W, Barth RF, Eriksson S, Tjarks W. The synthesis and biochemical evaluation of thymidine analogues substituted with nido carborane at the N-3 position Applied Radiation and Isotopes. 61: 1125-1130. PMID 15308203 DOI: 10.1016/j.apradiso.2004.05.023  0.32
2004 Shin SS, Byun Y, Lim KM, Choi JK, Lee KW, Moh JH, Kim JK, Jeong YS, Kim JY, Choi YH, Koh HJ, Park YH, Oh YI, Noh MS, Chung S. In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives. Journal of Medicinal Chemistry. 47: 792-804. PMID 14761182 DOI: 10.1021/jm020545z  0.32
2003 Johnsamuel J, Byun Y, Jones TP, Endo Y, Tjarks W. A convenient method for the computer-aided molecular design of carborane containing compounds Bioorganic and Medicinal Chemistry Letters. 13: 3213-3216. PMID 12951095 DOI: 10.1016/S0960-894X(03)00674-7  0.32
2003 Johnsamuel J, Byun Y, Jones TP, Endo Y, Tjarks W. A new strategy for molecular modeling and receptor-based design of carborane containing compounds Journal of Organometallic Chemistry. 680: 223-231. DOI: 10.1016/S0022-328X(03)00389-9  0.32
2002 Lee KW, Choi YH, Joo YH, Kim JK, Shin SS, Byun YJ, Kim Y, Chung S. A facile one-pot synthesis of 4,5-diaryl-2,2-dimethyl-3(2H)-furanones Bioorganic and Medicinal Chemistry. 10: 1137-1142. PMID 11836125 DOI: 10.1016/S0968-0896(01)00388-1  0.32
2001 Shin SS, Noh MS, Byun YJ, Choi JK, Kim JY, Lim KM, Ha JY, Kim JK, Lee CH, Chung S. 2,2-Dimethyl-4,5-diaryl-3(2H)furanone derivatives as selective cyclo-oxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 11: 165-8. PMID 11206450 DOI: 10.1016/S0960-894X(00)00634-X  0.32
1995 Jin YH, Bae M, Byun YJ, Kim JH, Chun MW. Synthesis and antiviral activity of fluoro sugar nucleosides 1: Studies on 4′-azido-2′-deoxy-2′-fluoro-arabinofuranosyl nucleosides Archives of Pharmacal Research. 18: 364-365. DOI: 10.1007/BF02976334  0.32
Show low-probability matches.